Study of Knowledge Translation of Clinical Practice Guidelines for Ventilator Associated Pneumonia (ABATEVAP)

August 31, 2010 updated by: Canadian Critical Care Trials Group

Active Observational Study of the Adoption and Transfer of Clinical Practice Guidelines Through Education, for Ventilator Associated Pneumonia (ABATE VAP Study)

The purpose of this prospective, multicentre, time-series study is to develop, implement, refine, and evaluate a sustainable behaviour change strategy in the intensive care unit (ICU).

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Background:

In order to improve the care of our patients, it is necessary for research evidence to be translated into clinical practice. There are gaps in our understanding of knowledge translation (KT) and this is evident in the Intensive Care Unit (ICU), specifically as it applies to the prevention, diagnosis and treatment of ventilator-associated pneumonia (VAP). VAP is associated with a high burden of illness in the critically ill and there is an extensive amount of research evidence on this disease. It has been demonstrated that best practice as defined by research evidence is not uniformly applied to VAP. In addition, recent advances in VAP knowledge need be disseminated and implemented in order to improve patient safety and outcomes from VAP. A systematic process of knowledge transfer is crucial to translate this research into evidence-based bedside practice and the development and implementation of evidence based Clinical Practice Guidelines (CPGs) may facilitate VAP knowledge uptake. In addition, there is a need to study knowledge translation (KT) in the ICU since there is little information about optimal KT and CPG implementation strategies in this environment and efforts that are effective in other clinical areas may not result in meaningful change in the ICU.

Research Question:

What is the effect of VAP CPGs implemented by a multidisciplinary behaviour change strategy (consisting of multifaceted educational strategies led by local opinion leaders and augmented with reminders) on VAP guideline concordance and on clinical VAP outcomes in the ICU?

Research Plan:

Data will only be collected on consecutive patients mechanically ventilated for at least 48 hours. The following health care professionals will be studied to assess the behaviour change strategy for the VAP CPGs: physicians (intensivists, ICU fellows, ICU rotating residents), nurses, respiratory therapists, dieticians, physiotherapists and ICU administrators.

The study will be conducted in 3 phases:

  1. Development of a behaviour change strategy consisting of three components:

    • Local opinion leader team
    • Educational strategy
    • Reminder system
  2. Prospective implementation of the behaviour change strategy over a 24 month period
  3. Prospective evaluation of the behaviour change strategy over a 24 month period

    • Concordance with VAP guidelines over time
    • Factors associated with VAP guideline concordance
    • Clinical VAP outcomes pre- and post-guideline implementation

Study Type

Observational

Enrollment (Actual)

1320

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • New Westminister, British Columbia, Canada, V3L 3W4
        • Royal Columbian Hospital, University of British Columbia
      • Vancouver, British Columbia, Canada, V6Z 1Y6
        • St. Paul Hospital, University of British Columbia
      • Victoria, British Columbia, Canada, V8R 1J8
        • Vancouver Island Health Research Centre
    • Ontario
      • Hamilton, Ontario, Canada, L8N 4A6
        • St. Joseph's Healthcare, McMaster University
      • Kingston, Ontario, Canada, K7L 2V7
        • Kingston General Hospital, Queen's University
      • Ottawa, Ontario, Canada, K1H 8L7
        • The Ottawa Hospital, University of Ottawa
      • Thunder Bay, Ontario, Canada, P7B 6V4
        • Thunder Bay Regional Health Sciences Centre
      • Toronto, Ontario, Canada, M4N 3M5
        • Sunnybrook Health Sciences Centre, University of Toronto
      • Toronto, Ontario, Canada
        • William Osler Health Centre
      • Windsor, Ontario, Canada, N4A 1E1
        • Hotel Dieu Grace Hospital
    • Pennsylvania
      • Danville, Pennsylvania, United States, 17821-4400
        • Geisinger Health Centre, Temple University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients invasively mechanically ventilated > 48 hours in the critical care setting.

Description

Inclusion Criteria:

  • Age >= 17 years old
  • Mechanically ventilated > 48 hours < 96 hours

Exclusion Criteria:

  • Previous enrollment in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
Patients receiving invasive mechanical ventilation > 48 hours.
Implementation of clinical practice guideline for ventilator associated pneumonia through education.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: John Muscedere, MD, Kingston General Hospital, Queen's University
  • Study Chair: Tasmin Sinuff, MD, PhD, Sunnybrook Health Sciences Centre, University of Toronto
  • Principal Investigator: Daren Heyland, MD, Kingston General Hospital, Queen's University
  • Principal Investigator: Deborah Cook, MD, St. Joseph's Healthcare, McMaster University
  • Principal Investigator: Peter Dodek, MD, St. Paul's University, University of British Columbia
  • Principal Investigator: Redouane Bouali, MD, The Ottawa Hospital, University of Ottawa
  • Principal Investigator: Sean Keenan, MD, Royal Columbian Hospital, University of British Columbia
  • Principal Investigator: Kevin Eva, PhD, McMaster University
  • Principal Investigator: Brenda Morgan, RN, London Health Sciences Centre, University of Western Ontario
  • Principal Investigator: Lori Hand, RRT, Hamilton Health Sciences Centre, McMaster University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2007

Study Completion (Actual)

July 1, 2010

Study Registration Dates

First Submitted

February 12, 2007

First Submitted That Met QC Criteria

February 12, 2007

First Posted (Estimate)

February 13, 2007

Study Record Updates

Last Update Posted (Estimate)

September 1, 2010

Last Update Submitted That Met QC Criteria

August 31, 2010

Last Verified

August 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe